Overview

Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema

Status:
Completed

Trial end date:
2018-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the mean gain in best corrected visual acuity and the number of intravitreal ranibizumab (IVR) injections under the combination treatment of IVR, focal/grid laser and panretinal photocoagulation. Our hypothesis is that suitable photocoagulation decreases the number of IVR injections.

Phase:

Phase 4

Details

Lead Sponsor:

Shinshu University

Treatments:

Ranibizumab